•
Dec 31, 2019

Thermo Fisher Q4 2019 Earnings Report

Thermo Fisher Scientific reported strong Q4 2019 results, exceeding goals with excellent revenue and earnings growth.

Key Takeaways

Thermo Fisher Scientific reported a 5% increase in revenue to $6.83 billion for the fourth quarter of 2019. GAAP diluted EPS increased by 12% to $2.49, and adjusted EPS increased by 9% to $3.55. The company saw growth across all segments, driven by innovation and strategic acquisitions.

Revenue increased by 5% to $6.83 billion.

GAAP diluted EPS increased by 12% to $2.49.

Adjusted EPS increased by 9% to $3.55.

The company launched the Ion Torrent Genexus next-generation sequencing instrument.

Total Revenue
$6.83B
Previous year: $6.51B
+4.9%
EPS
$3.55
Previous year: $3.25
+9.2%
Organic Revenue Growth
5%
Adjusted Operating Margin
24.9%
Previous year: 24.8%
+0.4%
Gross Profit
$3.16B
Previous year: $3.05B
+3.6%
Cash and Equivalents
$2.4B
Previous year: $2.1B
+14.1%
Free Cash Flow
$1.64B
Previous year: $1.52B
+8.2%
Total Assets
$58.2B
Previous year: $56.2B
+3.5%

Thermo Fisher

Thermo Fisher

Thermo Fisher Revenue by Segment

Forward Guidance

The company will provide 2020 financial guidance during its earnings conference call this morning at 8:30 a.m. Eastern time.

Revenue & Expenses

Visualization of income flow from segment revenue to net income